Patients with AMI complicated by HF, particularly those developing HF after admission, face high hospital mortality and underutilization of effective cardiac therapies.
Results from this nationwide registry suggest that the incidence and hospital death rates associated with HF complicating AMI remain high. Patients developing HF after hospital admission are at even greater risk than those presenting with HF. Effective cardiac therapies remain underutilized in these patients, and the reasons for this underutilization need to be explored.
Spencer et al. (Tue,) studied this question.